UroGen Pharma Ltd. (URGN) FY2026 YTD Q2 Statement of Cash Flows
2026-01-01 to 2026-06-30
Statement of Cash Flows
2026-01-01 to 2026-06-30
Swipe to see the full flow
Chart details
UroGen Pharma Ltd. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026
Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Dec 31, 2025
- 112,095,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
- Operating activities
- negative 78,322,000 US dollars. Net cash used.
- Net loss
- negative 37,925,000 US dollars
- Accounts payable and accrued expenses
- 12,228,000 US dollars
- Employee related accrued expenses
- negative 1,263,000 US dollars
- Prepaid expenses and other current assets
- 1,896,000 US dollars
- Other non-current assets
- negative 3,600,000 US dollars
- Inventory
- negative 8,125,000 US dollars
- Accounts receivable, net
- negative 55,675,000 US dollars
- Amortization of right-of-use assets
- 1,167,000 US dollars
- Acquisitions of IPR&D
- 0 US dollars
- Share-based compensation
- 9,958,000 US dollars
- Amortization of discount on long-term debt
- 1,178,000 US dollars
- Accrued financing on prepaid forward obligation
- 2,050,000 US dollars
- Accretion on marketable securities
- negative 250,000 US dollars
- Restricted deposit
- negative 1,000 US dollars
- Depreciation and amortization
- 153,000 US dollars
- Other current liabilities
- 0 US dollars
- Lease liabilities
- negative 113,000 US dollars
- Investing activities
- negative 19,015,000 US dollars. Net cash used.
- Maturities of marketable securities
- 5,879,000 US dollars
- Purchases of property and equipment
- negative 114,000 US dollars
- Purchases of marketable securities
- negative 24,780,000 US dollars
- Financing activities
- 65,704,000 US dollars. Net cash provided.
- Proceeds from pre-funded warrant issuance, net of issuance costs
- 0 US dollars
- Proceeds from exercise of options into ordinary shares
- 1,066,000 US dollars
- Proceeds from issuance of long-term debt, net
- 65,346,000 US dollars
- Principal payments on finance leases
- negative 708,000 US dollars
- Operating adjustment reconciliation
- 106,952,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 66,412,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 24,894,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 0 US dollars
- Ending cash on Jun 30, 2026
- 80,462,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
- Cash sources and uses
- 177,799,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- negative 31,633,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- Operating cash flow
- negative 78,322,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 114,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- negative 78,436,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$37.93M − net operating adjustments $40.40M = operating cash −$78.32M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 78,322,000 US dollars minus 114,000 US dollars equals negative 78,436,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!